Fluoro-deoxyglucose positron emission tomography imaging for the detection of occult disease in multiple myeloma

Br J Haematol. 2002 Apr;117(1):133-5. doi: 10.1046/j.1365-2141.2002.03407.x.


Positron emission tomography with 2-deoxy-2-[18]fluoro-D-glucose (FDG-PET) imaging has been extensively used to detect occult metastatic malignant lesions in patients with carcinoma. We describe its use in three patients with multiple myeloma, each representing a particular clinical situation in which this imaging modality offered advantages over plain radiography, computerized tomography or magnetic resonance imaging. FDG-PET provides a whole body image showing sites of occult disease. This is of particular value in patients with non-secretory myeloma, solitary plasmacytoma or for those that relapse with focal disease following autologous or allogeneic stem cell transplantation.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Bone and Bones / diagnostic imaging*
  • Female
  • Fluorodeoxyglucose F18*
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / diagnostic imaging*
  • Tomography, Emission-Computed*


  • Fluorodeoxyglucose F18